The U.S. Food and Drug Administration has accepted Novo Nordisk's marketing application for an oral version of its ...

Canadian oil producer Imperial Oil posted a rise in first-quarter profit on Friday, driven primarily by stronger margins in ...

Britain's blue-chip index notched its 15th consecutive session of gains - its longest winning streak on record - as investors ...

Viking is developing what might be a game-changing medication in the segment.

In 2023, experts decided against adding obesity drugs to the World Health Organisation's essential medicines list.

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new study published Wednesday.

Young US women with breast cancer are not dying from the disease as often as a decade ago, researchers reported at the ...

Health Canada begins a priority review of semaglutide 2.4 mg, a weekly treatment by Novo Nordisk for MASH, a liver disease ...

GLP-1 drug prices are falling. That's good news for patients, but perhaps not such good news for pharmaceutical stock ...

More than a billion people now have obesity worldwide, according to the WHO, and around 70% of them live in low and ...

Anthropic is preparing to carry out its first employee share buyback, valuing the firm at $61.5 billion. The initiative also ...

On this week’s episode of the Readout LOUD, we review President Trump’s first 100 days, the return of biotech M&A, strong ...